Quick Nav
Pharmacy Times

FDA Considers Posting Names of Unapproved Drugs

Published Online: Monday, September 1, 2003   [ Request Print ]

    Concern over medication mix-ups due to ?sound-alike? drugs is causing the FDA to reconsider its longstanding opposition to public disclosure of the names of drugs still in the research and development pipeline. According to officials at the FDA?s medication error prevention branch, the agency may soon propose new procedures for placing the names of unapproved drugs on the Internet?a move that some say could reduce confusion with other products and therefore lower the potential risk of medication mix-ups for patients.
Related Articles
No Result Found

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.

Become a Member
Forgot Password?